NCT04385888

Brief Summary

This study will investigate whether low-calorie sweeteners (LCS) are helpful or harmful for preventing diabetes complications among children with Type 1 Diabetes (T1D).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 13, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

October 28, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

August 26, 2025

Completed
Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

3.2 years

First QC Date

May 8, 2020

Results QC Date

August 20, 2024

Last Update Submit

August 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glycemic Variability

    Change in Time in Range (TIR)

    Baseline vs Weeks 11-12

Secondary Outcomes (2)

  • Visceral Adiposity

    Baseline vs. Week 12

  • Change in Inflammatory Cytokines (TNF-alpha)

    Baseline vs Week 12

Study Arms (2)

Low-calorie sweetener restriction

EXPERIMENTAL

Participants will be instructed to avoid low-calorie sweetened beverages and other sources of low-calorie sweeteners, and to instead consume unsweetened alternatives, such as plain or sparkling water for 12 weeks.

Behavioral: Low-calorie sweetener restriction

Usual consumption/control

NO INTERVENTION

Participants will continue low-calorie sweetener consumption, as usual.

Interventions

Participants will avoid low-calorie sweetened beverages and other sources of low-calorie sweeteners for 12 weeks and will instead consume unsweetened alternatives, such as still or sparkling water

Low-calorie sweetener restriction

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child 6-12 years old
  • Report consumption of ≥ 12 oz. beverages with sucralose (+/- ace-K) or aspartame+ace-K per day
  • Child has had a diagnosis of T1D for at least one year
  • Parent/guardian has reliable phone and internet access
  • Parent/guardian and child both speak English
  • Child is enrolled in the Diabetes Program at Children's National Hospital

You may not qualify if:

  • Child under 6 years of age
  • Child older than 12 years of age
  • Child consumes foods with low-calorie sweeteners more than 3 times per week
  • Child consumes condiments with low-calorie sweeteners more than 3 times per week
  • Child has poorly managed chronic disease other than T1D or is taking medications other than insulin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's National Hospital

Washington D.C., District of Columbia, 20010, United States

Location

Related Publications (1)

  • Sylvetsky AC, Moore HR, Kaidbey JH, Halberg SE, Cogen FR, DiPietro L, Elmi A, Goran MI, Streisand R. Rationale and design of DRINK-T1D: A randomized clinical trial of effects of low-calorie sweetener restriction in children with type 1 diabetes. Contemp Clin Trials. 2021 Jul;106:106431. doi: 10.1016/j.cct.2021.106431. Epub 2021 May 8.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Results Point of Contact

Title
Allison Sylvetsky
Organization
George Washington University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 8, 2020

First Posted

May 13, 2020

Study Start

October 28, 2020

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

August 26, 2025

Results First Posted

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations